UK Health Podcasts UK Health RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ancient volcanic eruptions, and peer pressure —from robots
Several thousand years ago the volcano under Santorini in Greece—known as Thera—erupted in a tremendous explosion, dusting the nearby Mediterranean civilizations of Crete and Egypt in a layer of white ash. This geological marker could be used to tie together many ancient historical events, but the estimated date could be off by a century. Contributing Correspondent Lizzie Wade joins host Sarah Crespi to talk about a new study that used tree rings to calibrate radiocarbon readings—and get closer to pinning down a date. The findings also suggest that scientists may need to change their standard radiocarbon dating calib...
Source: Science Magazine Podcast - August 16, 2018 Category: Science Authors: Science Magazine Source Type: podcasts

Hodgkin lymphoma: difficulties faced in geriatrics
At the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK, Wendy Osborne, MBBS (Hons), MRCP, FRCPath, of Newcastle upon Tyne Hospitals NHS Foundation Trust, Ne... Author: VJHemOnc Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts

The importance of BSH Annual Meetings
The British Society for Haematology (BSH) 2018 Annual Meeting in Liverpool, UK, had a record number of clinical experts in attendance. Speaking from the Annual Meeting, Simon Rule, MD, from Plymouth U... Author: VJHemOnc Added: 07/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 24, 2018 Category: Cancer & Oncology Source Type: podcasts

BSH 2018: interdisciplinary highlights
Stephen Devereux, FRCP, FRCPath, PhD, of Kings College Hospital NHS Foundation Trust, London, UK gives his highlights from the the British Society for Haematology (BSH) 2018 Annual Scientific Meeting... Author: VJHemOnc Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Using genomics to predict CLL progression
Speaking from the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK, Niamph Appleby, MB, BAO, BCh, MRCPI, FRCPath, from the the Royal Marsden NHS Foundation T... Author: VJHemOnc Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Novel agents for sickle cell disease
Speaking from the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, in Liverpool, UK, Bart Biemond, MD, PhD, from the Academic Medical Centre, Amsterdam, Netherlands, discusses new... Author: VJHemOnc Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Future improvements in developing CLL therapy
While the treatment landscape of chronic lymphocytic lymphoma (CLL) has been exciting with many breakthrough therapies, there are still key areas for improvement. Speaking from the British Society for... Author: VJHemOnc Added: 07/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 13, 2018 Category: Cancer & Oncology Source Type: podcasts

What does the public think of the NHS?
It ’s been quite a year for the NHS - it just turned 70, had a winter crisis like never before, got over junior doctor strikes, but then was hit by a series of scandals about breast screening, and now opiate prescriptions. At the same time, we’ve seen demonstrations in favour of the service and e ven widespread public backing for more money. So how do all of these things mix into the way in which the British public view the NHS? In this podcast, Ben Page - chief exec of Ipsos MORI, the polling company, joins us to discuss the fluctuations in public opinion. Read the provocation: https://ww w.bmj.com/content/361/bmj...
Source: The BMJ Podcast - July 12, 2018 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

What does the public think of the NHS?
It’s been quite a year for the NHS - it just turned 70, had a winter crisis like never before, got over junior doctor strikes, but then was hit by a series of scandals about breast screening, and now opiate prescriptions. At the same time, we’ve seen demonstrations in favour of the service and even widespread public backing for more money. So how do all of these things mix into the way in which the British public view the NHS? In this podcast, Ben Page - chief exec of Ipsos MORI, the polling company, joins us to discuss the fluctuations in public opinion. Read the provocation: https://www.bmj.com/content/361/bmj.k2...
Source: The BMJ Podcast - July 12, 2018 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Clinical hematology: moving forward
Willem Ouwehand, MD, PhD, of the University of Cambridge, Cambridge, UK updates us on developments in clinical hematology at the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, L... Author: VJHemOnc Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts

The future of CAR T-cell therapy
Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, describes his role in a debate at the British Society for Haematology (BSH) 2018 Annual S... Author: VJHemOnc Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts

ENDEAVOUR: carfilzomib/dexamethasone therapy for relapsed MM
In this interview, recorded at the British Society for Haematology (BSH) 2018 Annual Meeting in Liverpool, UK, Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, of University College London Hospitals NHS F... Author: VJHemOnc Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts

How does heterogeneity in TP53 activity affect MM prognosis?
Tumor suppressor gene TP53 is associated with aggressive disease activity when inactivated in a variety of tumor types, including multiple myeloma (MM). Speaking from the British Society for Haematolo... Author: VJHemOnc Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts

How does heterogeneity in TP53 activity affect MM prognosis?
Tumor suppressor gene TP53 is associated with aggressive disease activity when inactivated in a variety of tumor types, including multiple myeloma (MM). Speaking from the British Society for Haematolo... Author: VJOncology Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts

Diagnosing and treating Gaucher disease
Speaking from the British Society for Hematology (BSH) 2018 Annual Scientific Meeting in Liverpool, UK, Derralyn Hughes, MA, DPhil, FRCP, FRCPath, of the Royal Free London NHS Foundation Trust, London... Author: VJHemOnc Added: 07/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 4, 2018 Category: Cancer & Oncology Source Type: podcasts